Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Olema Pharmaceuticals Inc
OLMACurrent price
12.4 USD
-0.16 USD (-1.27%)
Last closed
12.52 USD
Company
www.olema.com
ISIN
US68062P1066
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
665 435 584 USD
Yield for 12 month
-27.65 %
1Y
3Y
5Y
10Y
15Y
OLMA
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 3 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer; and OP-1250 combine with CDK4/6 inhibitors palbociclib, ribociclib, and alpelisib in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive human epidermal growth factor receptor 2-negative breast cancer, as well as develops OPERA-01 for the of ER+/HER2- advanced or metastatic breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California. Address: 780 Brannan Street, San Francisco, CA, United States, 94103
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
27.67 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-377 000 USD
Last Year
-1 658 000 USD
Current Quarter
-94 000 USD
Last Quarter
-88 000 USD
Key Figures OLMA
1 year
3 years
5 years
10 years
EBITDA
-122 267 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-35.47 %
PEG Ratio
–
Return On Equity TTM
-56.4 %
Wall Street Target Price
27.67 USD
Revenue TTM
–
Book Value
3.97 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-2.04 USD
Diluted Eps TTM
-2.04 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics OLMA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History OLMA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation OLMA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-3.326
Price Book MRQ
2.9293
Financials OLMA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators OLMA
For 52 weeks
8.51 USD
17.79 USD
50 Day MA
12.01 USD
Shares Short Prior Month
8 511 108
200 Day MA
12.14 USD
Short Ratio
16.23
Shares Short
8 495 375
Short Percent
25.76 %
BeatStart